by admin | Dec 2, 2025 | News & Opinions
By James O’Donnell – MIT Technology Review – As technologists frame AI as either utopian or dystopian, two researchers offer a third option. Right now, despite its ubiquity, AI is seen as anything but a normal technology. There is talk of AI systems...
by admin | Dec 1, 2025 | News & Opinions
By American Medical Journal – A NEW phase 3 clinical trial has revealed that stem cells can help prevent heart failure in patients recovering from acute myocardial infarction. The study found that intracoronary infusion of mesenchymal stem cells significantly...
by admin | Nov 28, 2025 | News & Opinions
By Genetic Engineering and Biotechnology News – Scientists at the University of Glasgow developed a bioengineered bone marrow (BM) model that helped them to evaluate potential use of a combined CRISPR-CAR T cell therapy in the treatment of acute myeloid...
by admin | Nov 27, 2025 | News & Opinions
By Rockefeller University – ScienceDaily Scientists found that low serine levels spark a shift in hair stem cells, transforming them into wound-healing experts — with diet playing a possible role. Rockefeller scientists uncovered how hair follicle stem cells can...
by admin | Nov 26, 2025 | News & Opinions
By Jonah Feldman, Frederick Locke, MD – Targeted Oncology – On June 26, 2025, the FDA announced the elimination of the Risk Evaluation and Mitigation Strategy (REMS) program that applied to 6 chimeric antigen receptor (CAR) T-cell therapies approved to...
by admin | Nov 25, 2025 | News & Opinions
By Paul Knoepfler – STAT – The company that claimed to revive the dire wolf continues to raise ethical questions De-extinction firm Colossal Biosciences announced Tuesday that it was acquiring animal cloning firm Viagen. The same day, retired NFL all-star...
